2007
DOI: 10.2215/cjn.04121206
|View full text |Cite
|
Sign up to set email alerts
|

A Proposed Taxonomy for the Podocytopathies

Abstract: A spectrum of proteinuric glomerular diseases results from podocyte abnormalities. The understanding of these podocytopathies has greatly expanded in recent years, particularly with the discovery of more than a dozen genetic mutations that are associated with loss of podocyte functional integrity. It is apparent that classification of the podocytopathies on the basis of morphology alone is inadequate to capture fully the complexity of these disorders. Herein is proposed a taxonomy for the podocytopathies that … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

3
205
0
1

Year Published

2007
2007
2022
2022

Publication Types

Select...
6
4

Relationship

2
8

Authors

Journals

citations
Cited by 230 publications
(213 citation statements)
references
References 86 publications
3
205
0
1
Order By: Relevance
“…Our results indicate that podocytopathy plays a central role in preeclamptic nephropathy, thereby contributing, at least in part, to the increased risk of developing FSGS later in life. This notion is consistent with previous reports that podocytopathy plays a role in other forms of FSGS, and it lends credence to speculation that targeting the podocyte may have therapeutic value (32,33). Whether the activation of parietal epithelial cells is a mechanism to compensate for ongoing podocyte injury and loss, or whether these cells contribute to glomerular injury, or both, remains to be investigated.…”
Section: Discussionsupporting
confidence: 92%
“…Our results indicate that podocytopathy plays a central role in preeclamptic nephropathy, thereby contributing, at least in part, to the increased risk of developing FSGS later in life. This notion is consistent with previous reports that podocytopathy plays a role in other forms of FSGS, and it lends credence to speculation that targeting the podocyte may have therapeutic value (32,33). Whether the activation of parietal epithelial cells is a mechanism to compensate for ongoing podocyte injury and loss, or whether these cells contribute to glomerular injury, or both, remains to be investigated.…”
Section: Discussionsupporting
confidence: 92%
“…Healthy podocytes in vivo are generally held to be terminally differentiated growth-arrested cells. Proliferation of dysregulated podocytes (or perhaps podocyte progenitor cells) underlies pathogenesis of collapsing glomerulopathy (3,26). Synaptopodin mRNA expression was suppressed in tsT-podocytes under growth-permissive conditions and CDK4-podocytes compared with primary podocytes (Fig.…”
Section: Discussionmentioning
confidence: 94%
“…For example, podocyte numbers are reduced in proportion to the severity of injury and the magnitude of proteinuria is related to the extent of reduced podocyte number. Reduced podocyte number is a predictor of progression in patients with diabetic nephropathy, IgA nephropathy, and focal segmental glomerulosclerosis (FSGS) [5-7]. Independently from the type of insult (genetic, mechanical, immunological, toxic), podocytes respond in an apparently stereotypic pattern.…”
Section: Introductionmentioning
confidence: 99%